Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80.8M
-
Number of holders
-
694
-
Total shares
-
74.6M
-
Shares change
-
+1.12M
-
Total reported value, excl. options
-
$20.5B
-
Value change
-
+$338M
-
Put/Call ratio
-
2.76
-
Number of buys
-
289
-
Number of sells
-
-328
-
Price
-
$275.33
Significant Holders of IDEXX LABORATORIES INC /DE - Common Stock (IDXX) as of Q2 2019
705 filings reported holding IDXX - IDEXX LABORATORIES INC /DE - Common Stock as of Q2 2019.
IDEXX LABORATORIES INC /DE - Common Stock (IDXX) has 694 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 74.6M shares
of 80.8M outstanding shares and own 92.25% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (9.25M shares), BlackRock Inc. (6.46M shares), Fundsmith LLP (4.47M shares), BAMCO INC /NY/ (3.94M shares), STATE STREET CORP (3.67M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.18M shares), BLAIR WILLIAM & CO/IL (1.57M shares), Invesco Ltd. (1.47M shares), GEODE CAPITAL MANAGEMENT, LLC (1.44M shares), and AMERICAN CENTURY COMPANIES INC (1.44M shares).
This table shows the top 694 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.